Hi. I’m here because my mom (88) has non hodgkins follicular lymphoma and it’s recently spread to her lymph nodes in...

I appreciate you sharing your mom's situation—this is clearly important to you. Let me address your questions systematically, starting with what the medical evidence shows for follicular lymphoma treatment, then the specific concerns you've raised.

---

1) Follicular Lymphoma Treatment Options (Including Bispecific Antibodies)

Your oncologist is discussing real, evidence-based treatment approaches. Let me explain what's happening and why the recommendations matter for your mom's specific situation.

Understanding Follicular Lymphoma Spread

According to the NCCN Guidelines for Patients: Follicular Lymphoma, follicular lymphoma (FL) is a slow-growing B-cell lymphoma that typically forms in lymph nodes. When it spreads to chest lymph nodes (as in your mom's case), this is called "extranodal disease" (disease outside the original location). This is important because it affects which treatment approaches doctors consider.

What Bispecific Antibodies Are (And Why They're Discussed)

Bispecific antibodies are a newer class of immunotherapy—not traditional chemotherapy. According to NCCN Guidelines, bispecific antibodies (BsAbs) work by:

• Binding to TWO different proteins at the same time: CD20 (found on lymphoma cells) and CD3 (found on T cells)
• Essentially "introducing" the patient's own T cells to the cancer cells
• Allowing T cells to recognize and kill the lymphoma cells

Examples include:

• Epcoritamab-bysp (Epkinly)
• Mosunetuzumab-axgb (Lunsumio)
• Glofitamab-gxbm (Columvi)

These are FDA-approved for certain lymphoma situations and represent a shift away from traditional "carpet bombing" chemotherapy toward more targeted immune approaches.

The "Very Sick" Conversation—What Your Oncologist Likely Means

When your oncologist says treatment "could make her very sick," they're being honest about side effects. According to NCCN Guidelines, immunotherapies like bispecific antibodies can cause:

• Cytokine Release Syndrome (CRS): A condition where immune cells release large amounts of signaling molecules, causing fever, muscle aches, nausea, headache, fast heartbeat, low blood pressure, and trouble breathing
• Fatigue, diarrhea, and inflammation
• These are DIFFERENT from traditional chemo side effects (hair loss, severe bone marrow suppression)

However, the NCCN Guidelines note that for follicular lymphoma specifically, bispecific antibodies often have more durable responses (longer-lasting benefit) compared to older approaches.

Age Consideration (Your Mom is 88)

This is crucial. The NCCN Guidelines don't have a specific age cutoff for treatment, but your oncologist should be considering:

• Your mom's overall health (not just age)
• Her kidney and liver function
• Her ability to tolerate side effects
• Her goals (cure vs. quality of life vs. symptom control)

This is a conversation worth having explicitly: "Doctor, given my mom is 88, what are we trying to achieve here—cure, extended remission, or symptom control? And how does that change the treatment recommendation?"

---

2) The "Cure" Question

Your oncologist said treatment "could cure her." For follicular lymphoma specifically:

According to NCCN Guidelines and the medical literature, follicular lymphoma is generally considered a chronic disease rather than something with a traditional "cure." However:

• Many patients achieve complete remission (no signs of disease)
• Some remissions last many years
• Treatment can be very effective at controlling the disease

The honest framing: Your oncologist likely means "could achieve complete remission and long-term disease control" rather than a permanent cure. This is still meaningful—but it's important to clarify what "cure" means in this context.

---

3) Ivermectin for Follicular Lymphoma

I need to be direct here: I don't have evidence-based research from authoritative cancer sources (NCCN, ASCO, NCI, American Cancer Society) supporting ivermectin as a treatment for follicular lymphoma.

Here's why your oncologist likely won't consider it:

• No clinical trial data: Ivermectin is an antiparasitic medication. There are no published clinical trials showing efficacy in follicular lymphoma
• No mechanism of action: We don't have evidence that ivermectin targets the CD20+ B cells that cause follicular lymphoma
• Risk of delay: Using unproven treatments can delay proven therapies that work
• Regulatory status: The FDA has not approved ivermectin for lymphoma treatment

What I understand you might be thinking: Ivermectin has been discussed in some alternative health circles for various conditions, but this is different from evidence-based cancer treatment.

My honest recommendation: If you're interested in complementary approaches alongside standard treatment, ask your oncologist about:

• Nutrition support
• Exercise programs (which DO have evidence for cancer patients)
• Stress management
• Acupuncture for symptom management

These can support treatment without replacing it.

---

Questions to Ask Your Oncologist About Your Mom's Situation

Given what you've shared, here are specific questions that would help clarify the plan:

1. "Given my mom is 88, what is our primary goal—cure, remission, or symptom control?"

2. "You mentioned bispecific antibodies. Can you explain why this is better than other options for her specific situation?"

3. "What does 'very sick' mean specifically? What side effects should we prepare for, and how are they managed?"

4. "What's the timeline? How long will treatment take, and when would we know if it's working?"

5. "What happens if she decides treatment is too difficult? What are the alternatives?"

6. "Are there clinical trials she might be eligible for?" (Bispecific antibodies are sometimes available through trials)

7. "How will we monitor her during treatment, and what symptoms mean we need to stop or adjust?"

---

Summary

✅ Strong Evidence: Bispecific antibodies are real, FDA-approved treatments for follicular lymphoma with good response rates

✅ Important Conversation: Your mom's age (88) and overall health should drive a discussion about goals—cure vs. quality of life

❌ Limited Evidence: Ivermectin doesn't have clinical trial support for lymphoma. Your oncologist's hesitation is based on lack of evidence, not closed-mindedness

The bottom line: Your oncologist is recommending evidence-based treatment. The conversation should focus on whether the benefits (disease control) are worth the side effects for your mom specifically—not on unproven alternatives.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Would it help to talk through how to have this conversation with your oncologist, or do you have other questions about follicular lymphoma specifically?